Josiane Sabbadini Neves

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

Centro de Ciências da Saúde

Unidade:

Instituto de Ciências Biomédicas

Departamento:

Docentes/ICB

ORCID:

https://orcid.org/0000-0002-6645-1715


Formação:

  • Beth Israel Deaconess Medical Center - Harvard Medical School

    | Pós-Doutorado | 2005 - 2009

  • Universidade Federal do Rio de Janeiro

    Ciências Biológicas (Farmacologia e Química Medicinal) | Doutorado | 2000 - 2004

  • Universidade Federal do Rio de Janeiro

    Farmácia | Graduação | 1996 - 1999
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(100.00% artigos com DOI)

Titulo DOI Ano
Extracellular Sombrero Vesicles are Hallmarks of Eosinophilic Cytolytic Degranulation in Tissue Sites of Human Diseases 10.1093/jleuko/qiae079 2024
Eosinophils: Focus on DNA extracellular traps 10.1016/j.lfs.2022.121191 2022
ATRvD1 Attenuates Renal Tubulointerstitial Injury Induced by Albumin Overload in Sepsis-Surviving Mice 10.3390/ijms222111634 2021
Adenosine Diphosphate Improves Wound Healing in Diabetic Mice Through P2Y12 Receptor Activation 10.3389/fimmu.2021.651740 2021
Structural and Signaling Events Driving Aspergillus fumigatus-Induced Human Eosinophil Extracellular Trap Release 10.3389/fmicb.2021.633696 2021
Neutrophil and Eosinophil DNA Extracellular Trap Formation: Lessons From Pathogenic Fungi 10.3389/fmicb.2021.634043 2021
Histoplasma capsulatum -induced extracellular DNA trap release in human neutrophils 10.1111/cmi.13195 2020
Mac-1 triggers neutrophil DNA extracellular trap formation to Aspergillus fumigatus independently of PAD4 histone citrullination 10.1002/jlb.4a0119-009rr 2020
Editorial: Severe Eosinophilic Disorders: Mechanisms and Clinical Management 10.3389/fimmu.2019.02118 2019
Eosinophils in fungal diseases: An overview 10.1002/jlb.4mr1117-473r 2018
Allergic Bronchopulmonary Aspergillosis-A Luminal Hypereosinophilic Disease With Extracellular Trap Cell Death 10.3389/fimmu.2018.02346 2018
Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus 10.1016/j.jaci.2017.07.048 2018
Pharmacological modulation of reactive oxygen species (ROS) improves the airway hyperresponsiveness by shifting the Th1 response in allergic inflammation induced by ovalbumin 10.1080/10715762.2017.1364377 2017
Cysteinyl Leukotrienes in Eosinophil Biology: Functional Roles and Therapeutic Perspectives in Eosinophilic Disorders 10.3389/fmed.2017.00106 2017
JM25-1, a Lidocaine Analog Combining Airway Relaxant and Antiinflammatory Properties 10.1097/aln.0000000000000919 2016
CD63 is tightly associated with intracellular, secretory events chaperoning piecemeal degranulation and compound exocytosis in human eosinophils 10.1189/jlb.3a1015-480r 2016
Purinergic P2Y12 Receptor Activation in Eosinophils and the Schistosomal Host Response 10.1371/journal.pone.0139805 2015
Multifaceted Roles of Cysteinyl Leukotrienes in Eliciting Eosinophil Granule Protein Secretion 10.1155/2015/848762 2015
Characterization of the inflammatory response during Ehrlich ascitic tumor development 10.1016/j.vascn.2014.09.001 2014
Pulmonary Antifibrotic Mechanisms Aspirin-Triggered Lipoxin A 4 Synthetic Analog 10.1165/rcmb.2012-0462oc 2013
Functional Extracellular Eosinophil Granules: A Bomb Caught in a Trap 10.1159/000354934 2013
Eosinophil crystalloid granules: structure, function, and beyond 10.1189/jlb.0212067 2012
Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules 10.1016/j.jaci.2009.11.029 2010
Vesicle-mediated secretion of human eosinophil granule-derived major basic protein 10.1038/labinvest.2009.40 2009
Subcellular fractionation of human eosinophils: Isolation of functional specific granules on isoosmotic density gradients 10.1016/j.jim.2009.03.006 2009
A new paradigm for eosinophil granule-dependent secretion 10.4161/cib.2.6.9345 2009
Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology 10.1016/j.coi.2009.07.011 2009
Synthesis and antispasmodic activity of lidocaine derivatives endowed with reduced local anesthetic action 10.1016/j.bmcl.2007.11.122 2008
Eosinophil granules function extracellularly as receptor-mediated secretory organelles 10.1073/pnas.0804547105 2008
Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially 10.1189/jlb.0108058 2008
Antianaphylactic Properties of 7-Epiclusianone, a Tetraprenylated Benzophenone Isolated from 10.1055/s-2007-981534 2007
Evaluating the prophylactic potential of the phtalimide derivative LASSBio 552 on allergen-evoked inflammation in rats 10.1016/j.ejphar.2005.02.011 2005
Anti-Inflammatory and Analgesic Activities of the Latex Containing Triterpenes from Himatanthus sucuuba 10.1055/s-2000-8572 2000
Eventos:

(4.55% eventos com DOI)

Titulo DOI Ano
Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules 10.1016/j.jaci.2009.11.029 2010
Eosinophil Granules Function Extracellularly as Receptor-Mediated Secretory Organelles 2007
Eosinophil Granules Function Extracellularly as Receptor-Mediated Secretory Organelles 2007
Eosinophil Granules Function Extracellularly as Receptor-Mediated Secretory Organelles 2007
Evaluating the Prophylactic Potencial of the Phtalimide Derivative Lassbio 552 on allergen-evoked inflammation in rats 2005
LASSBio 552, a Phtalimide Derivative Prevents Airway Eosinophilia and Hiperreactivity in a Murine Model of Allergic Inflammation 2005
The Naturally Ocurring Compound INFAR-7 Reduces Allergic Airway Responses in Mice 2005
Evaluating the Prophylactic Potencial of the Phtalimide Derivative Lassbio 552 on allergen-evoked inflammation in rats 2004
A Novel Phenoxi-Phtalimid Acid Derivative LASSBio 552 Caused a Selective Inhibition of Allergen-Evoked Eosinophil Recruitment in Sensitized Rats 2003
Pharmacological Study of New Fenoxi-Phtalimidic Acid Derivatives with Potential Anti-Asthmatic Properties 2002
Bloqueio Seletivo do Infiltrado Eosinofílico Alérgico Observado após Tratamento com o Derivado Ftalimídico LASSBio 552 em Ratos Ativamente Sensibilizados 2002
Ação da Lidocaína sobre a Contração do Músculo Liso Intestinal, Espasmo Traqueal e Extravasamento Plasmático Cutâneo Causado por Alergeno 2002
Estudo do Perfil Antinflamatório e Analgésico do Composto LASSBio 455 Planejado como Possível Inibidor Seletivo da PGHS-2 2001
Anti-Inflammatory and Analgesic Profile of New Phenyl-Imidazolic Acylarydrazone Derivatives Planned as 5-LO and PGHS Inhibitors 2000
Atividade Analgésica de Novos Derivados Amino-Bipirazólicos Planejados como Possíveis Inibidores Seletivos de COX-2 2000
Estudo do Perfil Antinflamatório e Ulcerogênico de Derivados Sulfonil-Bipirazólicos Planejados como Possíveis Inibidores Seletivos da PGHS-2. 1999
Estudo do Perfil Antinflamatório e Analgésico de Derivados Sulfonil-Bipirazólicos Planejados como Possíveis Inibidores Seletivos da PGHS-2. 1999
Atividade antinflamatória de novos derivados benzotiazínicos sintetizados como inibidores de PGHS-2 e 5-LO 1998
Síntese e Avaliação Farmacológica de Novos derivados Bipirazólicos Sintetizados como possíveis Inibidores Seletivos da PGHS-2 1998
Planejamento, Síntese e Avaliação Farmacológica de Novos Protótipos de Inibidores Seletivos de PGHS-2 1998
Estudo da Atividade Antinflamatória e Ulcerogênica de Duas Séries de Derivados Benzotiazínicos Planejados como possíveis Inibidores Seletivos da PGHS-2 1998
Síntese e Avaliação Farmacológica de Novos Derivados N-Sulfonilarilidrazônicos: Analgésicos. 1998
Publicações:
Minha Rede: